HomeComparePME vs MRK

PME vs MRK: Dividend Comparison 2026

PME yields 55.56% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PME wins by $245841522809.15M in total portfolio value
10 years
PME
PME
● Live price
55.56%
Share price
$0.27
Annual div
$0.15
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$245841522809.20M
Annual income
$244,994,360,913,422,460.00
Full PME calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — PME vs MRK

📍 PME pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPMEMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PME + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PME pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PME
Annual income on $10K today (after 15% tax)
$4,722.22/yr
After 10yr DRIP, annual income (after tax)
$208,245,206,776,409,100.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, PME beats the other by $208,245,206,776,400,770.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PME + MRK for your $10,000?

PME: 50%MRK: 50%
100% MRK50/50100% PME
Portfolio after 10yr
$122920761404.63M
Annual income
$122,497,180,456,716,130.00/yr
Blended yield
99.66%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PME
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
0.2
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PME buys
0
MRK buys
0
No recent congressional trades found for PME or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPMEMRK
Forward yield55.56%2.76%
Annual dividend / share$0.15$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$245841522809.20M$56.8K
Annual income after 10y$244,994,360,913,422,460.00$9,798.13
Total dividends collected$245785764587.03M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: PME vs MRK ($10,000, DRIP)

YearPME PortfolioPME Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$21,811$11,111.11$11,206$366.19+$10.6KPME
2$68,636$45,298.26$12,650$502.35+$56.0KPME
3$339,883$266,442.08$14,407$694.19+$325.5KPME
4$2,829,857$2,466,182.89$16,585$967.82+$2.81MPME
5$41,408,120$38,380,172.35$19,342$1,363.89+$41.39MPME
6$1,094,028,187$1,049,721,498.42$22,913$1,947.19+$1094.01MPME
7$53,010,409,256$51,839,799,096.07$27,662$2,823.89+$53010.38MPME
8$4,751,792,239,232$4,695,071,101,328.11$34,159$4,173.35+$4751792.21MPME
9$791,740,089,513,756$786,655,671,817,777.90$43,337$6,308.80+$791740089.47MPME
10$245,841,522,809,202,180$244,994,360,913,422,460.00$56,776$9,798.13+$245841522809.15MPME

PME vs MRK: Complete Analysis 2026

PMEStock

Pingtan Marine Enterprise Ltd., together with its subsidiaries, engages in the ocean fishing business. The company catches a range of fish species, such as red fish, ribbon fish, sea catfish, seabream, shrimp, silver pomfret and seaperch, slender shad, sole fish, Spanish mackerel, and threadfin. As of December 31, 2021, it owned 51 squid jigging vessels, 26 trawlers, 25 seine vessels, 13 drifters, four longline fishing vessels, and 3 transport vessels, as well as had operating license rights to 20 drifters. The company serves various customers, including distributors, restaurant owners, and exporters in the People's Republic of China. Pingtan Marine Enterprise Ltd. is based in Fuzhou, the People's Republic of China.

Full PME Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PME vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PME vs SCHDPME vs JEPIPME vs OPME vs KOPME vs MAINPME vs JNJPME vs ABBVPME vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.